Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin
Cheng, Junjie2; Zhu, Yang2; Xing, Xin3; Xiao, Jianmin4; Chen, Hui5; Zhang, Hongwei2; Wang, Dan5; Zhang, Yuanyuan6; Zhang, Guilong1; Wu, Zhengyan4
刊名THERANOSTICS
2021
卷号11
关键词cisplatin ferroptosis anticancer theranostics manganese
ISSN号1838-7640
DOI10.7150/thno.53346
通讯作者Zhang, Guilong(glzhang@bzmc.edu.cn) ; Wu, Zhengyan(zywu@ipp.ac.cm) ; Liu, Yangzhong(liuyz@ustc.edu.cn)
英文摘要Background: Ferroptosis is a form of iron-dependent programmed cell death that differs from apoptosis with regards to both mechanism and cell morphology. Therefore, ferroptotic-based cancer therapy has shown significant potential to overcome the weaknesses of conventional therapeutics mediated by apoptosis pathways. Effective ferroptosis can be induced by the intracellular Fenton reaction that is dependent on the adequate supply of iron ions and H2O2 in cells. However, these are often insufficient due to intrinsic cellular regulation. Methods: In this study, we designed a cisplatin prodrug-loaded manganese-deposited iron oxide nanoplatform (Pt-FMO) to trigger intracellular cascade reactions that lead to generation of reactive oxygen species (ROS) to enhance ferroptotic effect. The Pt-FMO causes the tumor microenvironment responsive to release manganese, iron ions and Pt-drugs. As manganese is an element that is able to catalyze the Fenton reaction more effectively than iron, coupled with the Pt-drugs that can promote generation of H2O2 in cells, the Pt-FMO is expected to significantly strengthen catalysis of the Fenton reaction, which favors the ferroptotic effect. Moreover, the Pt-drugs will eventually function as cisplatin. Thus, Pt-FMO is an ideal candidate for tumor ferroptotic combined with apoptotic treatment. Results: In vivo results demonstrated that, at a dosage of only 8.89% Pt content, Pt-FMO is able to achieve a similar treatment effect as cisplatin. Hence, Pt-FMO exhibited significantly lower systemic toxicity compared to cisplatin. Additionally, Pt-FMO exhibits effective T-2-weighted MRI enhancement for tumor imaging. Conclusion: The Pt-FMO nanoplatform is designed to introduce mutual beneficial cascade reactions for promoting ferroptosis and apoptosis in combination with tumor MRI. The Pt-FMO system, which causes ferroptosis combined with apoptosis, can efficiently induce tumor cell death.
资助项目National Key R&D Program of China[2020YFA0710700] ; National Key R&D Program of China[2017YFA0505400] ; National Natural Science Foundation of China[21877103] ; National Natural Science Foundation of China[52021002] ; Anhui Provincial Natural Science Foundation[1908085QB77] ; Special Project of Central Government for Local Science and Technology Development of Shandong Province[YDZX20203700001291] ; Users with Excellence Program of Hefei Science Center CAS[2020HSC-UE016]
WOS研究方向Research & Experimental Medicine
语种英语
出版者IVYSPRING INT PUBL
WOS记录号WOS:000629071700021
资助机构National Key R&D Program of China ; National Natural Science Foundation of China ; Anhui Provincial Natural Science Foundation ; Special Project of Central Government for Local Science and Technology Development of Shandong Province ; Users with Excellence Program of Hefei Science Center CAS
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/121322]  
专题中国科学院合肥物质科学研究院
通讯作者Zhang, Guilong; Wu, Zhengyan; Liu, Yangzhong
作者单位1.Binzhou Med Univ, State Adm Tradit Chinese Med China, Sch Pharm, Key Lab Prescript Effect & Clin Evaluat, Yantai 264003, Peoples R China
2.Univ Sci & Technol China, Dept Pharm, Affiliated Hosp USTC 1, Div Life Sci & Med,Dept Chem, Hefei 230001, Peoples R China
3.Wannan Med Coll, Dept Stomatol, Affiliated Hosp 1, Wuhu 241000, Peoples R China
4.Chinese Acad Sci, Hefei Inst Phys Sci, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230031, Peoples R China
5.Anhui Med Univ, Stomatol Hosp & Coll, Dent Implant Ctr, Key Lab Oral Dis Res Anhui Prov, Hefei 230032, Peoples R China
6.Anhui Med Univ, Sch Life Sci, Hefei 230032, Peoples R China
推荐引用方式
GB/T 7714
Cheng, Junjie,Zhu, Yang,Xing, Xin,et al. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin[J]. THERANOSTICS,2021,11.
APA Cheng, Junjie.,Zhu, Yang.,Xing, Xin.,Xiao, Jianmin.,Chen, Hui.,...&Liu, Yangzhong.(2021).Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.THERANOSTICS,11.
MLA Cheng, Junjie,et al."Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin".THERANOSTICS 11(2021).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace